Nigeria Has Registered Sputnik V
The National Agency for Food and Drug Control of Nigeria (NAFDAC) has registered a Russian vaccine against the coronavirus "Sputnik V", the Russian Direct Investment Fund (RDIF) reported. The vaccine has already been approved by 68 countries, their total population is more than 3.7 billion people.
"Nigeria is the most populous country in Africa, and the approval of Sputnik V will allow us to use one of the safest and most effective vaccines in the world to protect human health. The approval of the vaccine in Nigeria will allow the country to fight the pandemic more successfully, " said Kirill Dmitriev, head of the RDIF (quoted on the RDIF website).
There are 211 million people living in Nigeria. Since the beginning of the pandemic, 167 thousand people infected with coronavirus have been identified in the country, 2.1 thousand people have died. On July 14, WHO announced the beginning of the third wave of the COVID-19 pandemic in the world. Before that, the organization called for the idea of revaccination to be abandoned for the time being and to help countries where they cannot even organize primary vaccination of medical workers.
The Russian Direct Investment Fund (RDIF, the sovereign fund of the Russian Federation) announces the registration of the Russian vaccine against the Sputnik V coronavirus by the National Food and Drug Control Agency of Nigeria (NAFDAC).
Nigeria has become the 68th State to approve the use of the Sputnik V vaccine. The total population of all countries that have approved Sputnik V is more than 3.7 billion people, or about half of the world's population.
Data on the use of Sputnik V during vaccination of the population in a number of countries (Argentina, San Marino, Serbia, Hungary, Bahrain, Mexico, the United Arab Emirates, the Philippines, etc.) demonstrate that Sputnik V is one of the safest and most effective vaccines against coronavirus. Sputnik V ranks second in the world in terms of the number of approvals received by state regulators.
The use of the Sputnik V vaccine has also been approved in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the United Arab Emirates, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, the Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon, San Marino, Ghana, Syria, Kyrgyzstan, Guyana, Egypt, Honduras, Guatemala, Moldova, Slovakia, Angola, Djibouti, Republic of the Congo, Sri Lanka, Laos, Iraq, Northern Macedonia, Kenya, Morocco, Jordan, Namibia, Azerbaijan, the Philippines, Cameroon, Seychelles, Mauritius, Vietnam, Antigua and Barbuda, Mali, Panama, India, Nepal, Bangladesh, Turkey, Albania and Maldives, Ecuador and Brazil.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said:
"Nigeria is the most populous country in Africa, and the approval of Sputnik V will allow us to use one of the safest and most effective vaccines in the world to protect human health. Sputnik V was created on a proven platform of human adenovirus vectors and is successfully used in more than 50 countries. The approval of the vaccine in Nigeria will allow the country to fight the pandemic more successfully."